Literature DB >> 18832091

Hypertonic saline reduces neutrophil-epithelial interactions in vitro and gut tissue damage in a mouse model of colitis.

Wolfgang Tillinger1, Declan F McCole, Stephen J Keely, Lone S Bertelsen, Paul L Wolf, Wolfgang G Junger, Kim E Barrett.   

Abstract

Transepithelial migration of polymorphonuclear neutrophils (PMN) plays a crucial role in inflammatory conditions of the intestine, such as inflammatory bowel diseases. Hypertonic saline (HS) exerts various inhibitory effects on PMN function. We hypothesized that HS could inhibit transepithelial migration of PMN and thereby prevent inflammatory events in experimental colitis. Isolated human PMN were treated with HS (40 mM), and their transmigration across a monolayer of T84 epithelial cells was induced by N-formyl-methionyl-leucyl-phenylalanine. Monolayer disruption was assessed by monitoring changes in transepithelial conductance in an Ussing chamber. Colitis in mice was induced by oral administration of dextran sulfate sodium (DSS). Animals were treated with 4 or 8 ml/kg of 7.5% saline intraperitoneally two times daily for 7 days. Controls received equivalent volumes of normal saline (NS, n = 6) or no intraperitoneal treatment (DSS, n = 12). The severity of inflammation was evaluated based on disease activity index and histology score. HS treatment of PMN in vitro significantly reduced cell migration and the disruption of T84 monolayers compared with untreated control cells (n = 5, P < 0.05). This effect of HS was dose dependent. HS treatment in vivo also reduced colitis-induced gut tissue damage, as indicated by an improved histology score compared with the NS and DSS groups. We conclude that HS inhibits transepithelial migration of PMN in vitro and gut tissue damage in vivo in a mouse model of colitis. Thus HS may have clinical value to reduce PMN-mediated intestinal damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832091      PMCID: PMC2685287          DOI: 10.1152/ajpregu.00412.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  29 in total

1.  Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran.

Authors:  D Nolte; M Bayer; H A Lehr; M Becker; F Krombach; U Kreimeier; K Messmer
Journal:  Am J Physiol       Date:  1992-11

2.  Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction.

Authors:  C A Parkos; C Delp; M A Arnaout; J L Madara
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

3.  Migration-associated volume changes in neutrophils facilitate the migratory process in vitro.

Authors:  S Rosengren; P M Henson; G S Worthen
Journal:  Am J Physiol       Date:  1994-12

4.  Resuscitation of hemorrhage with intraosseous infusion of hypertonic saline/dextran.

Authors:  G C Kramer; J C Walsh; R D Hands; P R Perron; R A Gunther; S Mertens; J W Holcroft; F W Blaisdell
Journal:  Braz J Med Biol Res       Date:  1989       Impact factor: 2.590

5.  Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid volumes.

Authors:  S Tølløfsrud; T Tønnessen; O Skraastad; H Noddeland
Journal:  Acta Anaesthesiol Scand       Date:  1998-02       Impact factor: 2.105

6.  Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial.

Authors:  M J Vassar; C A Perry; J W Holcroft
Journal:  J Trauma       Date:  1993-05

7.  Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock.

Authors:  L J Magnotti; J S Upperman; D Z Xu; Q Lu; E A Deitch
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

8.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

Review 9.  Multiple organ failure. Pathophysiology and potential future therapy.

Authors:  E A Deitch
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

10.  Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38.

Authors:  W G Junger; D B Hoyt; R E Davis; C Herdon-Remelius; S Namiki; H Junger; W Loomis; A Altman
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

View more
  5 in total

1.  Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF.

Authors:  Laurianne Van Landeghem; Julien Chevalier; Maxime M Mahé; Thilo Wedel; Petri Urvil; Pascal Derkinderen; Tor Savidge; Michel Neunlist
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

Review 2.  Hypertonic Solution in Severe COVID-19 Patient: A Potential Adjuvant Therapy.

Authors:  Matheus Gennari-Felipe; Leandro Borges; Alexandre Dermargos; Eleine Weimann; Rui Curi; Tania Cristina Pithon-Curi; Elaine Hatanaka
Journal:  Front Med (Lausanne)       Date:  2022-06-21

3.  Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation.

Authors:  Tiecheng Yu; Wolfgang G Junger; Changji Yuan; An Jin; Yi Zhao; Xueqing Zheng; Yanjun Zeng; Jianguo Liu
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-04       Impact factor: 4.249

4.  Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice.

Authors:  Kelley Mk Haarberg; Meghan J Wymore Brand; Anne-Marie C Overstreet; Catherine C Hauck; Patricia A Murphy; Jesse M Hostetter; Amanda E Ramer-Tait; Michael J Wannemuehler
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

5.  Fluid supplementation accelerates epithelial repair during chemical colitis.

Authors:  Juan F Burgueño; Jessica K Lang; Ana M Santander; Irina Fernández; Ester Fernández; Julia Zaias; Maria T Abreu
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.